CLOV vs. AUR

In the year-to-date period, CLOV achieves a 39.37% return, which is significantly higher than AUR's 7.94% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and Aurora Innovation, Inc. (AUR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current CLOV Sharpe Ratio is 4.08, which is higher than the AUR Sharpe Ratio of 1.18. The chart below compares the historical Sharpe Ratios of CLOV and AUR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither CLOV nor AUR has paid dividends to shareholders.

The maximum CLOV drawdown since its inception was -97.19%, roughly equal to the maximum AUR drawdown of -93.34%. Use the drawdown chart below to compare losses from any high point for CLOV and AUR. For additional features, visit the drawdowns tool.

The current volatility for Clover Health Investments, Corp. (CLOV) is 14.49%, while Aurora Innovation, Inc. (AUR) has a volatility of 37.44%. This indicates that CLOV experiences smaller price fluctuations and is considered to be less risky than AUR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Clover Health Investments, Corp. and Aurora Innovation, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.